Provided by Tiger Trade Technology Pte. Ltd.

Argenx SE

1,002.31
-4.7600-0.47%
Post-market: 1,002.310.00000.00%19:38 EDT
Volume:209.93K
Turnover:210.38M
Market Cap:62.68B
PE:38.24
High:1,008.93
Open:991.68
Low:988.69
Close:1,007.07
52wk High:1,072.75
52wk Low:661.85
Shares:62.54M
Float Shares:62.45M
Volume Ratio:0.99
T/O Rate:0.34%
Dividend:- -
Dividend Rate:- -
EPS(TTM):26.21
EPS(LYR):19.57
ROE:23.63%
ROA:11.63%
PB:7.45
PE(LYR):51.22

Loading ...

Argenx Price Target Maintained with a $1150.00/Share by Wedbush

Dow Jones
·
Sep 08

Argenx Se (ARGX) Gets a Buy from Jefferies

TIPRANKS
·
Sep 03

Argenx Price Target Maintained with a $1150.00/Share by Wedbush

Dow Jones
·
Sep 03

Argenx Se : Jefferies Raises Target Price to $1215 from $1140

THOMSON REUTERS
·
Sep 03

Movement Alert|Argenx SE Rises 3.06% in Regular Trading, Myositis Phase 3 Data Catalyst Continues as Institutions Raise Target Prices

Market Focus
·
Aug 27

European Equities Traded in the US as American Depositary Receipts Decline in Wednesday Trading

MT Newswires Live
·
Aug 26

Analysts Offer Insights on Healthcare Companies: Solventum Corporation (SOLV), Argenx Se (ARGX) and Spyre Therapeutics (SYRE)

TIPRANKS
·
Aug 26

Movement Alert|Argenx SE Rises 3.85% in Pre-Market Trading, Post-Pullback Recovery on Myositis Data Momentum and Analyst Upgrades

Market Focus
·
Aug 26

Argenx Se : Wells Fargo Raises Target Price to $1415 from $1350

THOMSON REUTERS
·
Aug 26

UBS upgrades Argenx Se (ARGX) to a Buy

TIPRANKS
·
Aug 26

Argenx : UBS Raises to Buy from Neutral

THOMSON REUTERS
·
Aug 26

European Equities Traded in the US as American Depositary Receipts Track Slightly Lower in Monday Trading

MT Newswires Live
·
Aug 24

Analysts Are Bullish on Top Healthcare Stocks: Enliven Therapeutics (ELVN), Argenx Se (ARGX)

TIPRANKS
·
Aug 24

European Equities Traded in the US as American Depositary Receipts Rise in Wednesday Trading

MT Newswires Live
·
Aug 19

Movement Alert|Argenx SE Rises 3.17% in Regular Trading, Multiple Analysts Affirm Myositis Data De-risks Vyvgart Opportunity

Market Focus
·
Aug 19

Argenx's Myositis Data Derisk Vyvgart Opportunity, Oppenheimer Says

MT Newswires Live
·
Aug 18

Argenx's Vyvgart Hytrulo Likely to Get FDA Approval for Myositis, RBC Says

MT Newswires Live
·
Aug 18

Argenx's Myositis Data Strengthen Efgartigimod Outlook, Morgan Stanley Says

MT Newswires Live
·
Aug 18

Argenx Se : Morgan Stanley Raises Target Price to $1230.00 from $1200.00

THOMSON REUTERS
·
Aug 18

Argenx price target raised to $1,150 from $1,050 at Wedbush

TIPRANKS
·
Aug 18